# Myocardial Screening in Fetuses With Congenital Cytomegalovirus (CMV) Infection

> **NCT02787382** · PHASE3 · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Disorder of Cardiac Function

## Interventions

- **DEVICE:** echocardiographic examination

## Key facts

- **NCT ID:** NCT02787382
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2019-06
- **Final completion:** 2019-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2016-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02787382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02787382, "Myocardial Screening in Fetuses With Congenital Cytomegalovirus (CMV) Infection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02787382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*